EmVenio Insights
Explore our resources, including blogs, whitepapers, press, videos, and more.
Walgreens and Boehringer Ingelheim Are Partnering to Improve Diversity in Clinical Trials
May 2, 2024 | Press Release
Joint collaborations bring Boehringer Ingelheim’s Phase III clinical trial to communities through Walgreens pharmacy clinical trial centers and EmVenio’s mobile research units, aimed at improving access to trials DEERFIELD, Ill. and RIDGEFIELD, Conn., May 2, 2024 — Walgreens and Boehringer…
Prime Healthcare, EmVenio Research and Health Wizz Announce Strategic Partnership and Launch of EmVenio Research Center at Prime Healthcare
April 16, 2024 | Press Release
Partnership to provide clinical research to patients across the country DURHAM, N.C., April 16, 2024 – Community research provider EmVenio Research and Prime Healthcare, an award-winning national health system, today announce their partnership to launch the EmVenio Research Center at…
Reflecting on Success and Innovation: A Recap of The World Vaccine Congress
April 15, 2024 | Blog
The recent World Vaccine Congress proved to be a pivotal moment for the industry, marking achievements, recognition, and inspiring discussions that propel us forward in the realm of clinical trials and vaccine development. As we gather our thoughts and reflections,…
February 2024 Community Engagement
March 26, 2024 | Blog
Over the past few months, EmVenio has led a series of impactful events in Alabama, Illinois, and Florida, to boost community well-being. These local connections raise awareness about the importance of clinical research and offer local residents the opportunity to…
PCM Trials Acquires EmVenio Research to Create the Most Patient-Centric Model for Hybrid and Decentralized Clinical Trials
February 23, 2024 | Press Release
EmVenio’s Community Research Site Network helps remove barriers for participation in clinical research for underrepresented communities Denver (February 23, 2024) – Denver-based PCM Trials, the largest independent mobile research nurse visit provider for decentralized clinical trials (DCTs), today announced the…
EmVenio Research’s 2023 Community Engagement Highlights
January 31, 2024 | Blog
Since sharing with you last, EmVenio has been actively involved in Oklahoma, Florida, and Alabama to organize a series of captivating events that contribute to the well-being of the local communities. Our presence at these events was driven by our…
EmVenio Community Research Site 3D Tour
January 3, 2024 | Blog
EmVenio’s Community Research Sites (CRS) serve as a groundbreaking solution to conduct clinical research in areas where underrepresented and diverse populations can be reached. Explore the immersive 3D video showcasing our innovative Community Research Sites (CRS). Unveil the potential of…
EmVenio Research November 2023 Community Engagement Overview
November 20, 2023 | Blog
Throughout recent months, EmVenio joined forces with local communities for a series of engaging events aimed at nurturing unity, promoting awareness, and fostering education. These inclusive gatherings ranged from health fairs that focused on well-being to vibrant celebrations of diverse…
Case Study – Timeline from First Conversation to SIV
November 14, 2023 | Case Study
At EmVenio, we understand that the start-up phase of a clinical trial can often be a time-consuming process (not to mention the years of development before the trial can begin). However, we are proud to share that our team has…
Free wellness and obesity screenings available to Oklahoma City residents
October 25, 2023 | Press Release
Oklahoma City residents concerned about diabetes or obesity have an opportunity to evaluate their health and wellness at no cost. EmVenio Research, a clinical research organization, is offering free health screenings at its mobile community research site, located at 1301…
Webinar: The Power of Community Engagement in Clinical Research
October 19, 2023 | Webinar
Gain insights into how customized and scalable solutions can advance community engagement in clinical trials. The main barriers preventing people from participating in clinical trials are a lack of awareness and convenient access. To effectively address this issue, it is crucial to reach…
Our research team continues momentum of growth with two new principal investigators
September 21, 2023 | Press Release
We’re thrilled to announce the addition of Michelle Mallitz, M.D., and Thomas Wade, M.D., to our team to serve as principal investigators. In their roles, they will oversee and conduct objective clinical research to ensure independent, high quality and reproducible…